Pancreaze approved for exocrine pancreatic insufficiency - MPR
Links shared publicly online about this topic.
- 1,243total visits
Pancreaze approved for exocrine pancreatic insufficiency - MPR
empr.com —
View full resource at empr.com
Tags: Pancreatic Disease, Cystic Fibrosis, Children's Health, FDA, News
Most Recently Shared on April 13, 2010 at 4:27 pm By:
MPR News: Pancreaze approved for exocrine pancreatic insufficiency: The FDA has approved Pancreaze (pancrelipase d... http://bit.ly/bfVFzA
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
MNT Cystic Fibrosis Health News
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 15, 2011 at 12:08 am By:
Drugs and Devices OW OW Health
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pa... http://bit.ly/kZWxyW #drug
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 11:36 pm By:
FDA Approves Creon (pancrelipase) Infant-Specific Dosage Strength - http://bit.ly/jAdfb4
FDA approves J&JPRD's PANCREAZE NDA
news-medical.net — “Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE" (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the dige” View full resource at news-medical.net
Most Recently Shared on April 15, 2010 at 4:57 am By:
FDA approves J&JPRD's PANCREAZE NDA: Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced ... http://bit.ly/9HsmuA
FDA Approves Pancreatic Enzyme Product, Pancreaze
drugs.com — “Pancreaze (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Pancreaze side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2010 at 11:44 pm By:
FDA Approves Pancreatic Enzyme Product, Pancreaze - http://bit.ly/c6pGCd
Pancreaze approved for exocrine pancreatic insufficiency - ONA
oncologynurseadvisor.com — “The FDA has approved Pancreaze (pancrelipase delayed-release capsules, from McNeil Pediatrics) for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 13, 2010 at 3:24 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Pancreaze approved for exocrine pancreatic insufficiency http://goo.gl/fb/QlZhQ
FDA clears Eurand's pancreatic enzyme drug Zenpep - Related Stories - AAP SmartBrief
smartbrief.com — “Eurand in Amsterdam gained FDA approval for its lead product, pancreatic enzyme drug Zenpep, for children age 1 and older as well as adults. The treatment, which is indicated for exocrine pancreatic insufficiency, will be available in four dosages in the U.S. next quarter. <a href='/servlet/aaRedire” View full resource at smartbrief.com
Most Recently Shared on September 1, 2009 at 3:02 am By:
Clara Song Physician, Doctor, and Pediatrician
FDA clears Eurand's pancreatic enzyme drug Zenpep http://sbne.ws/r/2FrT
Eurand Granted FDA Approval for Zenpep
drugs.com — “Zenpep (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Zenpep side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2009 at 7:33 pm By:
Eurand Granted FDA Approval for Zenpep - http://bit.ly/3I6xA6
Medical News: FDA Formally Approves Creon Pancrelipase - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- The FDA has approved the Creon brand of delayed-release pancrelipase for treatment of exocrine pancreatic insufficiency.” View full resource at medpagetoday.com
Most Recently Shared on May 1, 2009 at 6:56 pm By:
FDA Formally Approves Pancrelipase http://medpagetoday.com/14021
Advertisement
